Raymond James Trust N.A. Raises Stake in Stevanato Group S.p.A. (NYSE:STVN)

Raymond James Trust N.A. increased its stake in shares of Stevanato Group S.p.A. (NYSE:STVN) by 22.6% in the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 12,556 shares of the company’s stock after buying an additional 2,317 shares during the period. Raymond James Trust N.A.’s holdings in Stevanato Group were worth $251,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in the stock. Tri Locum Partners LP bought a new stake in shares of Stevanato Group in the 2nd quarter worth approximately $10,370,000. Thrivent Financial for Lutherans bought a new stake in shares of Stevanato Group in the second quarter valued at $30,477,000. Thornburg Investment Management Inc. lifted its position in shares of Stevanato Group by 279.1% during the 2nd quarter. Thornburg Investment Management Inc. now owns 746,218 shares of the company’s stock valued at $13,690,000 after buying an additional 549,378 shares during the last quarter. Comgest Global Investors S.A.S. grew its stake in shares of Stevanato Group by 56.8% during the 2nd quarter. Comgest Global Investors S.A.S. now owns 394,120 shares of the company’s stock worth $7,228,000 after acquiring an additional 142,754 shares during the period. Finally, Raymond James & Associates increased its holdings in Stevanato Group by 21.8% in the 3rd quarter. Raymond James & Associates now owns 281,455 shares of the company’s stock worth $5,629,000 after acquiring an additional 50,380 shares during the last quarter.

Stevanato Group Price Performance

Shares of NYSE STVN opened at €20.00 ($21.05) on Thursday. The stock has a fifty day moving average of €19.47 and a 200-day moving average of €19.63. The company has a current ratio of 1.81, a quick ratio of 1.21 and a debt-to-equity ratio of 0.22. Stevanato Group S.p.A. has a fifty-two week low of €16.56 ($17.43) and a fifty-two week high of €34.73 ($36.56).

Stevanato Group (NYSE:STVN) last posted its earnings results on Tuesday, November 5th. The company reported €0.12 ($0.13) earnings per share for the quarter, missing analysts’ consensus estimates of €0.13 ($0.14) by (€0.01) (($0.01)). Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. The company had revenue of €277.90 million for the quarter, compared to analysts’ expectations of €274.36 million. During the same period in the previous year, the firm earned $0.16 EPS. The firm’s quarterly revenue was up 2.4% compared to the same quarter last year. Sell-side analysts forecast that Stevanato Group S.p.A. will post 0.5 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Citigroup cut their target price on shares of Stevanato Group from $30.00 to $28.00 and set a “buy” rating for the company in a research report on Wednesday, August 7th.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.